Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential
Consun achieved amazing 2021 results and is undervalued. Wanbangde’s intention to acquire Consun at high price is a catalyst. Shares have big...
542 Views
Investing in HK Stocks
If you invest in Western markets this would be enough, but not in Asian markets where the trust factor is a lot lower, and where ownership is more...
926 Views
China Traditional Chinese Medicine Possible Privatisation
Sinopharm Hongkong, the controlling shareholder, is currently exploring a privatisation proposal. At the last close price, the downside risk is low...
707 Views
HK Buyback League Table: Ronshine, China Star Ent, Consun
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
469 Views
Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma
Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...
489 Views